Tag(s):
FTC won’t back down on pay-for-delay reform
Wednesday, 25 May 2011
The US Federal Trade Commission (FTC) has petitioned the Third Circuit Court of Appeals in support of class action plaintiffs that are challenging pay-for-delay agreements in the pharmaceutical industry.
FTC would review a new Merck/Sanofi-Aventis JV
Premium Article - Monday, 08 February 2010
Drug makers Sanofi-Aventis and Merck are expected to reignite their animal-health joint venture in the coming weeks, exposing the companies to a fresh round of antitrust scrutiny by the US Federal Trade Commission.
Canada and US approve Merck/Schering Plough
Premium Article - Friday, 30 October 2009
The end is in sight for pharmaceuticals company Merck’s proposed US$41 billion acquisition of rival Schering Plough with regulatory approval coming from both Canada’s Competition Bureau and the US Federal Trade Commission yesterday.
DG Comp clears Merck/Schering Plough
Premium Article - Friday, 23 October 2009
The European Commission has today approved US pharmaceuticals company Merck’s proposed $31 billion acquisition of US-based health-care company Schering-Plough.
ACCC clears Merck/Schering Plough
Premium Article - Wednesday, 14 October 2009
Australia's Competition and Consumer Commission has today announced that undertakings adopted by the companies mean it will allow pharmaceuticals company Merck's $41 billion acquisition of rival Schering Plough.
Search GCR
Register for Free GCR Daily News
GCR December 2011
In this issue:
Surveys: New York, Israel • US Assistant Attorney General • Year in review • Isolde Goggin interview • Ricardo Napolitani interview
GCR Live Events
Mar
02
Law Leaders Asia-Pacific 2012
Organiser: Global Competition Review
Fri, 2nd March - Sat, 3rd March
Singapore, Singapore
Mar
14
Mar
27
2nd Annual GCR Awards Dinner
Organiser: Global Competition Review
Tue, 27th March
Washington DC, USA
Apr
24
Broadcasting and Competition Law 2012
Organiser: Global Competition Review
Tue, 24th April
London, UK
May
09
